The mek1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma

Mikhail S. Chesnokov, Imran Khan, Yeonjung Park, Jessica Ezell, Geeta Mehta, Abdelrahman Yousif, Linda J. Hong, Ronald J. Buckanovich, Akimasa Takahashi, Ilana Chefetz

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number1369
Pages (from-to)1-20
Number of pages20
JournalCancers
Volume13
Issue number6
DOIs
StatePublished - Mar 2 2021

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Cancer stem-like cells
  • High-grade serous ovarian carcinoma
  • MEK1/2
  • Proliferation
  • Trametinib

Cite this